Trials / Completed
CompletedNCT02800824
Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the bioequivalence between the Test Product Budesonide rectal aerosol foam and Reference Product Uceris® rectal aerosol foam after a single-dose in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide | |
| DRUG | Uceris |
Timeline
- Primary completion
- 2016-06-01
- First posted
- 2016-06-15
- Last updated
- 2022-01-13
Source: ClinicalTrials.gov record NCT02800824. Inclusion in this directory is not an endorsement.